EECP in Patients with Ischemic Heart Failure: What Does the Research Show?

This post is an excerpt from an article originally published in 2012 by the National Library of Medicine. Click the link at the bottom to read the full article.

Heart failure caused by reduced blood flow to the heart (ischemic heart failure) often leads to symptoms such as chest pain, breathlessness, fatigue, and reduced exercise capacity. Along with standard medical treatment,Enhanced External Counterpulsation (EECP) has been studied as a non-invasive therapy to improve blood circulation and quality of life in selected patients.

Overview of the Study

A prospective clinical study published in the National Library of Medicine (2012) evaluated the effects of EECP in patients with coronary artery disease (CAD) and chronic ischemic heart failure. The study included 68 patients, of whom 47 completed EECP therapy, while 21 patients who did not undergo EECP served as the comparison group.

Researchers assessed whether EECP could improve symptoms and influence important clinical markers associated with heart failure.

Key Takeaway

The study found that EECP therapy was associated with improvements in symptoms and functional status in appropriately selected patients with ischemic heart failure. These findings support EECP as a valuable non-invasive adjunct to guideline-directed medical therapy for patients who continue to experience symptoms despite optimal treatment.

Note: EECP is not a replacement for medications or other recommended heart failure treatments. Suitability for EECP should be determined by a qualified cardiologist after a comprehensive clinical evaluation.

Reference: Clinical Effects of Enhanced External Counterpulsation Treatment in Patients with Ischemic Heart Failure, National Library of Medicine (2012).

Read the Full Article →